Author Archives: admin
Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
U.S. Representative Celeste Maloy (R-UT) on Aug. 19 toured the Biologic Input Output Systems (BIOS) lab, part of the University of Utah’s Craig H. Neilsen Rehabilitation Hospital, to observe research into prosthetics innovation. Led by University of Utah NeuroRobotics Lab Director and BIOS Chief Scientist Jacob “Jake” George, alongside BIOS Chief Development Officer Tim Miller, […]
BYU and BioUtah Connect Utah’s Life Sciences Industry at Annual Networking Lunch
BioUtah and BYU’s College of Life Sciences hosted the annual BYU/BioUtah Networking Lunch on August 7 at BYU’s Life Sciences Building in Provo. Nearly 100 people attended out of more than 100 registrants, bringing together life sciences companies from across the state with BYU’s research and tech transfer community. The lunch is one piece of […]
BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention
The Utah Pavilion will serve as a gathering place to help convention attendees discover the state’s vibrant life sciences industry and the sector’s unique culture of collaboration that drives innovation.
nView Medical Surpasses 1,000 Surgeries
nView medical announced that its nView s1 system has surpassed 1,000 surgeries, marking an important milestone in the clinical use of the company’s intraoperative 3D imaging and navigation technology.
NanoKar Therapeutics Receives Funding From the University of Utah Launchpad Seed Fund to Advance Next-Generation CAR-T Cell Therapy Platform
University of Utah Launchpad Seed Fund award to support translational validation of NanoKar’s ITAM optimization platform, including CAR-T persistence and activity in solid tumor models.
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
Expanded collaboration adds manufacturing capacity, strengthens redundancy, and supports later-stage development planning for Ratio’s lead FAP-targeted radiotherapeutic candidate.
UNIVERSITY OF UTAH HEALTH DEDICATES JAMES LEVOY SORENSON CENTER FOR MEDICAL INNOVATION
Apr 14, 2026 University of Utah Health dedicated the James LeVoy Sorenson Center for Medical Innovation, a $50-million world-class hub designed to accelerate transformative research, medical device development, and life science training. Made possible by a generous $22 million lead gift from the Sorenson Legacy Foundation, the state-of-the-art facility serves as the new heart of […]
Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share
By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her again shortly after she delivered her first child. The visit was scheduled as a routine six-week newborn evaluation. As is common in primary care, the encounter extended beyond the infant to include the mother’s well-being. During the […]
University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings
Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The University of Utah has been named to the National Academy of Inventors’ (NAI) 2025 Top 100 U.S. Universities Granted U.S. Utility Patents list, further reinforcing its position as a national leader in research, innovation, and commercialization. This […]
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection […]
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target many types of cancer Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution study […]
TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS
TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover NEW ORLEANS–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits […]
